Concomitant inflammatory disease, IBD linked to higher health care use, costs

Patients with both chronic inflammatory disease and inflammatory bowel disease demonstrated higher health use and costs, compared with those with just chronic inflammatory disease, according to data published in BMC Rheumatology.“While multiple previous studies have assessed the incremental burden of IBD relative to controls without IBD, little is known on the burden of IBD in patients with pre-existing [chronic inflammatory disease],” David Hudesman, MD, of the New York University School of Medicine, and colleagues wrote.“A recent real-world analysis of the economic burdenRead More

Share on facebook
Share on twitter
Share on linkedin